Ready to Revolutionize Drug Development? Join us for #CERTAINTY Europe on 29-30 October in Mainz, Germany! This exclusive client event is designed for trailblazers in biosimulation, clinical pharmacology, AI, and regulatory science. Be at the forefront of drug development—connect with peers, gain invaluable insights, and drive the conversation forward. https://lnkd.in/ejDR83h5 Engage in discussions on critical topics such as: - The Impact of MIDD in Decision-Making - Generative AI in Non-Clinical Development - Accelerating Insights with Digital Data Flow Let's achieve greater certainty in drug development together. Register today while spots are still available: https://lnkd.in/ey8Avaub #globalCertainty #CertaintyEurope #CERTAINTY2024 #drugdevelopment
About us
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
- Website
-
https://www.certara.com
External link for Certara
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Radnor, Pennsylvania
- Type
- Public Company
- Specialties
- model-based drug discovery and development, scientific informatics, PK/PD modeling and simulation, PBPK modeling and simulation, trial design, drug development, regulatory writing, quantitative systems pharmacology, clinical pharmacology, quantitative systems toxicology, transparency and disclosure, model-based meta-analysis, regulatory strategy, regulatory publishing, market access, health economics and outcomes research, and real world evidence solutions
Locations
Employees at Certara
Updates
-
Biosimilars: Making lifesaving treatments more reachable. These lower-cost alternatives to biologics are expanding access to critical therapies. Our latest blog discusses how biosimilars are developed, approved, and impact both patients and the healthcare system. Read more: https://lnkd.in/egf-Pgk9 #Certara #Biosimilars #DrugDevelopment #Pharmaceuticals #Bioequivalence #Pharmacology #Pharmacokinetics #Pharmacodynamics #Biotechnology #GenericDrugs #ClinicalTrials #BiosimilarPathway #RegulatoryAffairs
-
In case you missed Dave Mitchell's Industry Theater Presentation at ACCP yesterday, here's a quick recap: We showcased how Certara provides flexible, scalable, end-to-end support to optimize your early development program. As a trusted, tech-enabled drug development partner, we integrate seamlessly with your team, offering cross-functional expertise to ensure your program’s success. We also shared a case study on how our early development accelerator can help advance your drug candidate more efficiently. Want to learn more? Stop by booth #3 and chat with Dave or head to https://lnkd.in/eSSEe2Vd for more details!
-
Heading to BioTechX Europe on October 9-10? Join Sean McGee, Director of Product, Certara.AI, as he dives into the transformative power of AI in life sciences with his talk, "Moving from Hype to Reality in Pharmaceutical AI Applications." Here’s what you can expect: - Utilizing GPTs to support structured content authoring in medical writing and regulatory submissions - Automating Data Transformation for eCTD standardization - Enhancing QSP Models for better target identification, PK/PD, and clinical trial design 📅 Date: October 9th 🕛 Time: 12:45 PM CEST 📍 Track: Large Language Models Join us to explore practical AI solutions that tackle today’s pharmaceutical challenges. Be sure to visit us at booth #822 to discover more about our cutting-edge solutions! For more details and to register, visit: https://lnkd.in/eXcq2nas #BioTechXUS #PharmaceuticalAI #CertaraAI #AIApplications #MedicalWriting #DataTransformation
-
Risk mitigation is important for drug development success. A Clinical Development Plan can help you identify potential challenges, develop contingency plans, and build resilience into your program. Proactively addressing risks can help you protect your investment. Check out our latest blog post to learn how to identify common risks, develop effective mitigation strategies, and build a strong drug development program. https://ow.ly/rhIx50T54Bj #Certara #DrugDevelopment #ClinicalTrials #Biotech #RegulatoryAffairs #ClinicalDevelopmentPlan #Biomarkers #PharmaIndustry #Pharma #DrugDevelopmentStrategy #TargetProductProfile
-
Day 1 of ACCP 2024 was a hit! 🎉 The day was filled with insightful sessions, poster presentations, and fantastic networking opportunities. Karen Rowland Yeo, PhD, joined an all-star Symposium panel to discuss key viewpoints in clinical drug development, modeling & simulation, and regulatory sciences. Her talk on obesity’s impact on drug development and the use of mechanistic modeling to assess pharmacokinetics in obese patients was enlightening. David Mitchell, PhD followed with an Industry Theater presentation, sharing how Certara’s comprehensive, integrative tech-enabled drug development services provide cross-functional expertise and accelerate drug candidate development efficiently. Day 2, here we come! #ACCP2024 #Networking #Innovation #Modeling #DrugDevelopement #ClinicalTrials #Regulatory #ClinicalResearch #FDA
-
+1
-
🌟 ACCP 2024 kicked off today with an exciting pre-conference workshop: "Physiologically-based Pharmacokinetic Analyses: Practical Applications in Clinical Drug Development." Our own Hannah Jones joined an expert panel featuring Kacey Anderson, Sumit Basu, Robert Bies, (University of Buffalo), Jongbong Lee, and Yuching Yang. The workshop explored key topics in PBPK modeling, offering practical insights and real-world case studies for users looking to enhance their drug development expertise. We can’t wait to connect with everyone tomorrow at Booth #3! Stay tuned for more updates! #ACCP2024 #PBPK #DrugDevelopment
-
Don't miss Caitlin Verrilli's upcoming presentation at the 8th Annual Pharma Pricing, Reimbursement & Market Access USA event in Philadelphia. Caitlin will present new research from Certara's US Access Strategy team on the impact the Inflation Reduction Act (IRA) has had on uptake of biosimilars. View the full conference agenda here: https://lnkd.in/e_W77cWp
-
We're excited to attend EUROTOX 2024 in Copenhagen, Denmark, from September 8-11! Catch our sessions on September 10: - 2:00-4:30 PM: Dr. Elias Zgheib on “Advances and Applications in Quantitative Systems Toxicology to Support Chemical Safety Assessment” (#286). - 4:00-6:00 PM: Dr. Barira Islam on “Bringing NGRA to life – A global joint effort for putting Next-Generation Risk Assessment into practice” (#194). Plus, check out our posters on September 9 at Tivoli Congress Hall: - 9:30 AM: “An extended in vitro CALUX read-out panel for the assessment of steroidogenesis modulation by endocrine disrupting chemicals on 4 hormonal modalities in the H295R steroidogenesis assay” (#329). - 9:30 AM: “ASPIS Academy: Empowering the Next Generation of Toxicologists” (#241). For more details on #EUROTOX2024, visit: https://lnkd.in/d256ERQp
-
We're thrilled to announce two brand-new courses designed in collaboration with the University of Florida to enhance your expertise in pharmacokinetics and pharmacometrics! Whether you're looking for flexible learning or an immersive in-person experience, Certara has you covered. 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝘁𝗼 𝗔𝗽𝗽𝗹𝗶𝗲𝗱 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗸𝗶𝗻𝗲𝘁𝗶𝗰𝘀: Dive into the intricate science of pharmacokinetics and its practical applications. This on-demand course is available all year-round, allowing you to register at your convenience and learn at your own pace. 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗺𝗲𝘁𝗿𝗶𝗰𝘀 𝗨𝘀𝗶𝗻𝗴 𝗣𝗶𝗿𝗮𝗻𝗮-𝗡𝗢𝗡𝗠𝗘𝗠 𝗮𝗻𝗱 𝗥𝗦𝗡𝗟𝗠𝗘: Join us for a 5-day in-person course where you will gain hands-on experience with nonlinear mixed effects modeling and learn to analyze population pharmacokinetic data using NONMEM and RsNLME, all while keeping track of model-building steps with the Pirana workbench. This 5-day immersive experience will take place Monday, 9/23 and end Friday, 9/27. Sessions will run from 9:00 AM to 5:00 PM, with plenty of breaks. We will conclude with an evening social event. *Please note: Completion of Course 1: Introduction to Applied Pharmacokinetics is a prerequisite for enrolling in this course. Bundle these courses or register individually! If you're interested in the 5-day in-person course, hurry to secure your spot—registration closes on September 1st! Learn more and register below: 👉 On-Demand Course: https://ow.ly/N0q450TcIqn 👉 5-Day In-Person Course: https://ow.ly/sBSR50TgLq2 Don't miss out on these incredible opportunities to advance your knowledge and skills!